TGF-β increases ECM accumulation and plays a major role in the development of chronic renal diseases through the induction of a downstream effector, which is a connective tissue growth factor, and by decreasing matrix degradation through the inhibition of proteases or activation of protease inhibitors [28]. The gene discussed is CCN2; the disease is chronic kidney disease.